Hypertension Trial, Recruiting NCT06826755 Sponsor: Mayo Clinic Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06826755
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 55 years old
  • You are female, have a uterus, and have at least one ovary
  • You have been diagnosed with high blood pressure, take medication for high blood pressure, or have had a blood pressure reading of 130/80 mmHg or higher at a doctor's office
  • If you take other medications, your dose has been stable for at least 2 months

Who may not be able to join:

  • You currently take prescription sleeping pills or melatonin supplements
  • You are pregnant or breastfeeding
  • You use tobacco, nicotine products, or vaping devices
  • You work night shifts
  • You take prescription-strength aspirin
  • You have severe lactose intolerance
  • You have a history of substance use disorder
  • You have a history of suicidal thoughts
  • You have been diagnosed with anemia in the past 5 years, or have had low hemoglobin levels in the past 12 months
  • You currently have an active cancer diagnosis
  • You experience severe daytime sleepiness, based on a score above 15 on a specific sleepiness questionnaire (confirm with trial site)
  • You are currently or have recently (within the past 2 months) taken part in another research study
  • You are unable to provide written consent or cannot speak and read English
  • Any other medical, location-related, or personal circumstances that would make it difficult to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
23 May 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Nocturnal Systolic Blood Pressure (SBP); Change in Nocturnal Diastolic Blood Pressure (DBP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov